UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000014222 |
|---|---|
| Receipt number | R000016553 |
| Scientific Title | Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis; a multicentre, open label, randomised control trial |
| Date of disclosure of the study information | 2014/08/01 |
| Last modified on | 2022/12/15 11:42:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/06/10 15:52:30 | ||
| 2 | Update | 2014/08/28 00:53:45 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2014/08/28 00:58:14 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2014/12/11 18:22:14 | Recruitment status |
|
| 5 | Update | 2016/06/10 10:41:35 | Randomization unit Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 6 | Update | 2016/06/10 10:43:53 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2016/07/11 12:28:35 | Last follow-up date |
|
| 8 | Update | 2017/06/12 19:04:16 | Last follow-up date |
|
| 9 | Update | 2018/12/14 17:27:30 | Last follow-up date |
|
| 10 | Update | 2019/06/14 14:03:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 11 | Update | 2019/06/14 14:09:16 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 12 | Update | 2020/08/28 23:05:31 | Recruitment status |
|
| 13 | Update | 2020/12/14 23:34:15 | Number of participants that the trial has enrolled |
|
| 14 | Update | 2022/12/15 11:10:19 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 15 | Update | 2022/12/15 11:42:41 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
